A novel immunosuppressive factor in bovine colostrum blocks activation of the interleukin 2 gene enhancer at the NFAT site

Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
D SambasivaraoV Paetkau

Abstract

A factor in bovine colostrum (colostrum inhibitory factor, CIF) inhibits interleukin 2 (IL2) production in activated T helper cells by blocking the accumulation of IL2 mRNA. To determine whether CIF blocks at the level of IL2 transcription, we introduced reporter plasmids into the human T leukemia cell line Jurkat by transient transfection. These contained the luciferase gene under the control of either the human IL2 upstream enhancer region (segments -326 to +45) or three repeats of the NFAT element contained within it (segments -255 to -285). Expression of luciferase in these cells was induced by phorbol myristate acetate plus a calcium ionophore. CIF inhibited induction of either construct as did cyclosporine, which is known to block activation of the NFAT element. CIF failed to inhibit several other enhancer elements. The NFAT-controlled luciferase gene system distinguishes CIF from other T cell inhibitory activities present in colostrum, in particular, TGF beta 1 and TGF beta 2 and the glucocorticoids. Stably transfected Jurkat cells behaved similarly to the transiently transfected ones with respect to inhibition by CIF and cyclosporine. The NFAT-luc assay is a useful technique for the rapid, sensitive measurement of CIF o...Continue Reading

References

Dec 1, 1991·Clinical and Experimental Immunology·J W HootonV Paetkau
Jul 1, 1990·Research in Immunology·C MunozC Dinarello
Mar 1, 1990·Clinical and Experimental Immunology·L Mincheva-NilssonS Hammarström
Aug 11, 1990·Nucleic Acids Research·T J NovakE V Rothenberg
Apr 1, 1988·Molecular and Cellular Biology·D B DurandG R Crabtree
Mar 15, 1988·Experientia·D Migliore-Samour, P Jollès
Dec 1, 1981·The Australian Journal of Experimental Biology and Medical Science·J K Kulski, P E Hartmann
Sep 1, 1995·Archives of Disease in Childhood. Fetal and Neonatal Edition·L SirotaH Bessler
Apr 1, 1995·Pediatric Research·R GarofaloA S Goldman
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·A HåkanssonC Svanborg
May 1, 1995·Cellular Immunology·P MandalapuV Paetkau
Jan 13, 1995·The Journal of Biological Chemistry·H SchwarzenbachP Matthias
Jan 1, 1994·Annual Review of Biochemistry·G R Crabtree, N A Clipstone
Jan 1, 1994·Journal of Reproductive Immunology·K H PalkowetzA S Goldman

❮ Previous
Next ❯

Citations

Jun 10, 1998·Veterinary Immunology and Immunopathology·B M AldridgeD P Lunn
Oct 30, 1998·Cellular Signalling·E S MasudaN Arai
Dec 26, 2006·Research in Veterinary Science·C BoudryJ-P Dehoux
Mar 28, 2003·American Journal of Physiology. Cell Physiology·Talat AfrozeMansoor Husain

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.